fluoxetine and ro13-9904

fluoxetine has been researched along with ro13-9904 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grandgirard, D; Leib, SL; Liechti, FD	1

Other Studies

1 other study(ies) available for fluoxetine and ro13-9904

Article	Year
The antidepressant fluoxetine protects the hippocampus from brain damage in experimental pneumococcal meningitis. Neuroscience, 2015, Jun-25, Volume: 297 Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Apoptosis; Brain Injuries; Ceftriaxone; Cytokines; Disease Models, Animal; Fluoxetine; Granulocyte Colony-Stimulating Factor; Hippocampus; Interleukin-3; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Meningitis, Pneumococcal; Rats; Recombinant Fusion Proteins; Streptococcus pneumoniae	2015

Article

Year

The antidepressant fluoxetine protects the hippocampus from brain damage in experimental pneumococcal meningitis.

Neuroscience, 2015, Jun-25, Volume: 297

Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Apoptosis; Brain Injuries; Ceftriaxone; Cytokines; Disease Models, Animal; Fluoxetine; Granulocyte Colony-Stimulating Factor; Hippocampus; Interleukin-3; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Meningitis, Pneumococcal; Rats; Recombinant Fusion Proteins; Streptococcus pneumoniae

2015